Advertisement
U.S. markets closed
Advertisement

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
66.62+0.36 (+0.54%)
At close: 04:00PM EDT
66.39 -0.24 (-0.35%)
After hours: 07:39PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Performance Outlook
Previous Close66.26
Open66.54
Bid66.58 x 900
Ask66.74 x 900
Day's Range66.04 - 66.74
52 Week Range53.52 - 76.56
Volume3,230,066
Avg. Volume4,875,129
Market Cap207.976B
Beta (5Y Monthly)0.17
PE Ratio (TTM)33.82
EPS (TTM)1.97
Earnings DateN/A
Forward Dividend & Yield1.45 (2.19%)
Ex-Dividend DateAug 10, 2023
1y Target Est83.71
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
34% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for AZN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Astrazeneca PLC
    Analyst Report: AstraZeneca PLCA merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more